# Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth

> **NCT04444011** · PHASE1 · UNKNOWN · sponsor: **Sihuan Pharmaceutical Holdings Group Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Anaprazole Sodium
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin
- **DRUG:** Bismuth

## Key facts

- **NCT ID:** NCT04444011
- **Lead sponsor:** Sihuan Pharmaceutical Holdings Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-10-15
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444011, "Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04444011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*